Aspira Women's Health Inc. (AWHL)
OTCMKTS · Delayed Price · Currency is USD
0.6217
-0.0083 (-1.31%)
At close: Dec 30, 2025
Aspira Women's Health Market Cap
Aspira Women's Health has a market cap or net worth of $26.52 million as of December 31, 2025. Its market cap has increased by 113.29% in one year.
Market Cap
26.52M
Enterprise Value
25.29M
Revenue
9.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.62
Market Cap Chart
Since September 29, 2000, Aspira Women's Health's market cap has decreased from 229.08M to 26.52M, a decrease of -88.42%. That is a compound annual growth rate of -8.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 26.87M | 128.70% |
| Dec 31, 2024 | 11.75M | -72.14% |
| Dec 29, 2023 | 42.17M | 1.77% |
| Dec 30, 2022 | 41.44M | -79.12% |
| Dec 31, 2021 | 198.46M | -71.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 704.73M |
| Elite Pharmaceuticals | 521.06M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 352.68M |
| CytoDyn | 342.85M |
| Silence Therapeutics | 298.05M |
| Nika Pharmaceuticals | 291.10M |